Flurbiprofen(FB),a nonsteroidal anti-inflammatory drug,is widely employed in treating ocular inflammation owing to its remarkable anti-inflammatory effects.However,the racemic nature of its commercially available form...Flurbiprofen(FB),a nonsteroidal anti-inflammatory drug,is widely employed in treating ocular inflammation owing to its remarkable anti-inflammatory effects.However,the racemic nature of its commercially available formulation(Ocufen^(R))limits the full potential of its therapeutic activity,as the(S)-enantiomer is responsible for the desired antiinflammatory effects.Additionally,the limited corneal permeability of FB significantly restricts its bioavailability.In this study,we successfully separated the chiral isomers of FB to obtain the highly active(S)-FB.Subsequently,utilizing ion-pairing technology,we coupled(S)-FB with various counter-ions,such as sodium,diethylamine,trimethamine(TMA),and l-arginine,to enhance its ocular bioavailability.A comprehensive evaluation encompassed balanced solubility,octanol-water partition coefficient,corneal permeability,ocular pharmacokinetics,tissue distribution,and in vivo ocular anti-inflammatory activity of each chiral isomer salt.Among the various formulations,S-FBTMA exhibited superior water solubility(about 1–12 mg/ml),lipid solubility(1<lgP_(ow)<3)and corneal permeability.In comparison to Ocufen^(R),S-FBTMA demonstrated significantly higher in vivo antiinflammatory activity and lower ocular irritability(such as conjunctival congestion and tingling).The findings from this research highlight the potential of chiral separation and ion-pair enhanced permeation techniques in providing pharmaceutical enterprises focused on drug development with a valuable avenue for improving therapeutic outcomes.展开更多
The degradation of partially hydrolyzed polyacrylamide(HPAM) found in alkaline/surfactant/polymer flooding sewage was investigated using Fenton-type reagents. Different Fenton reagent treatments for HPAM degradation w...The degradation of partially hydrolyzed polyacrylamide(HPAM) found in alkaline/surfactant/polymer flooding sewage was investigated using Fenton-type reagents. Different Fenton reagent treatments for HPAM degradation were compared. The effects of pH, hydrogen peroxide(H_(2)O_(2)), ferrous ion(Fe^(2+)), and tartaric ion(C_(4)H_(4)O_(6)^(2-)) concentrations were studied. The degradation reaction occurred within a wide range of pH(3–9). The HPAM degradation performance of photo-Fenton processes using solar light and UV were compared with that of the Fenton process. The degradation rate was found to be strongly dependent on the H_(2)O_(2)/Fe^(2+)/C_(4)H_(4)O_(6)^(2-)molar ratio. The HPAM degradation efficiency was 90%, and the chemical oxygen demand removal efficiency was 85%. HPAM could be degraded into a compound with a lower molecular weight, but it was difficult to achieve complete mineralization to CO_(2). The presence of intermediate products hindered further oxidation in the Fenton process.展开更多
基金financially supported by the National Postdoctoral Foundation of China(No.2023M730375)Liaoning Province Department of Education Project(No.LJKMZ20221365)the State Key Laboratory of Natural and Biomimetic Drugs(No.K202215)。
文摘Flurbiprofen(FB),a nonsteroidal anti-inflammatory drug,is widely employed in treating ocular inflammation owing to its remarkable anti-inflammatory effects.However,the racemic nature of its commercially available formulation(Ocufen^(R))limits the full potential of its therapeutic activity,as the(S)-enantiomer is responsible for the desired antiinflammatory effects.Additionally,the limited corneal permeability of FB significantly restricts its bioavailability.In this study,we successfully separated the chiral isomers of FB to obtain the highly active(S)-FB.Subsequently,utilizing ion-pairing technology,we coupled(S)-FB with various counter-ions,such as sodium,diethylamine,trimethamine(TMA),and l-arginine,to enhance its ocular bioavailability.A comprehensive evaluation encompassed balanced solubility,octanol-water partition coefficient,corneal permeability,ocular pharmacokinetics,tissue distribution,and in vivo ocular anti-inflammatory activity of each chiral isomer salt.Among the various formulations,S-FBTMA exhibited superior water solubility(about 1–12 mg/ml),lipid solubility(1<lgP_(ow)<3)and corneal permeability.In comparison to Ocufen^(R),S-FBTMA demonstrated significantly higher in vivo antiinflammatory activity and lower ocular irritability(such as conjunctival congestion and tingling).The findings from this research highlight the potential of chiral separation and ion-pair enhanced permeation techniques in providing pharmaceutical enterprises focused on drug development with a valuable avenue for improving therapeutic outcomes.
基金the Northeast Petroleum University Youth Science Foundation (No. 2019QNL-35)Guiding Science and Technology Plan Project of Daqing (No. zd-2021-39)。
文摘The degradation of partially hydrolyzed polyacrylamide(HPAM) found in alkaline/surfactant/polymer flooding sewage was investigated using Fenton-type reagents. Different Fenton reagent treatments for HPAM degradation were compared. The effects of pH, hydrogen peroxide(H_(2)O_(2)), ferrous ion(Fe^(2+)), and tartaric ion(C_(4)H_(4)O_(6)^(2-)) concentrations were studied. The degradation reaction occurred within a wide range of pH(3–9). The HPAM degradation performance of photo-Fenton processes using solar light and UV were compared with that of the Fenton process. The degradation rate was found to be strongly dependent on the H_(2)O_(2)/Fe^(2+)/C_(4)H_(4)O_(6)^(2-)molar ratio. The HPAM degradation efficiency was 90%, and the chemical oxygen demand removal efficiency was 85%. HPAM could be degraded into a compound with a lower molecular weight, but it was difficult to achieve complete mineralization to CO_(2). The presence of intermediate products hindered further oxidation in the Fenton process.
基金This work was supported by the National Natural Science Foundation of China(No.22273104,No.22022306,No.22288201)the Innovation Program for Quantum Science and Technology(No.2021ZD 0303305)+2 种基金the Strategic Priority Research Program of the Chinese Academy of Sciences(No.XDB0450202)Liaoning Revitalization Talents Program(No.XLYC 2203062)the Dalian Innovation Support Program(No.2021RD05).
